Sen-Jam Pharmaceutical

Quick facts

Phase 3 pipeline

• Ketotifen/Indomethacin · Allergy / Inflammation
  Ketotifen is a mast cell stabilizer and H1-receptor antagonist, while indomethacin is a non-selective NSAID that inhibits cyclooxygenase, together reducing allergic inflammation and pain.

Phase 2 pipeline

• SJP-223
• SJP-304

Phase 1 pipeline

• JMI-001
• Treatment E- Fexofenadine HCl 120mg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sen-Jam Pharmaceutical portfolio CI brief
• Sen-Jam Pharmaceutical pipeline updates RSS